Bionic 'Trojan Horse' nanoparticles based on Fe-Cu bimetallic MOFs enhance anti-tumor immunotherapy through multimodal synergistic effects.
The therapeutic efficacy of cisplatin-based chemotherapy for lung cancer is often limited by low tumor specificity and off-target toxicity. To address these challenges, we have developed a biomimetic "Trojan horse" nanoparticle (RLMPt-NPs), inspired by the multifunctional properties of biological membranes. The nanopar...